...
search icon
wve-img

Wave Life Sciences Ltd Share Price

WVE
NMQ
$12.68
-$0.12
(-0.94%)
1D
Industry: Pharmaceuticals Sector: Health Care

Wave Life Sciences Ltd Analyst Forecast

Wave Life Sciences Ltd Share Price Chart

Wave Life Sciences Ltd Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.38B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
2.24M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-1.77
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$5.28 L
$21.73 H
$12.68

About Wave Life Sciences Ltd, Common Stock

Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, an RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; WVE-007, a GalNAc-conjugated small interfering RNA designed to silence INHBE mRNA targeting obesity; WVE-N531, an exon skipping oligonucleotide for the treatment of Duchenne muscular dystrophy; and WVE-003, an allele-selective oligonucleotide for the treatment of Huntington's disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore. more

Industry: PharmaceuticalsSector: Health Care

Wave Life Sciences Ltd Stock Returns

Time FrameWVESectorS&P500
1-Week Return-5.72%-1.08%-1.38%
1-Month Return-10.83%-0.47%-1.81%
3-Month Return90.1%2.13%1.38%
6-Month Return44.75%17.04%5.68%
1-Year Return17.41%6.56%11.74%
3-Year Return202.63%16.78%65.15%
5-Year Return19.85%34.34%73.68%
10-Year Return32.08%137.88%260.03%

Wave Life Sciences Ltd Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue20.08M40.96M3.65M113.31M108.30M[{"date":"2020-12-31","value":17.72,"profit":true},{"date":"2021-12-31","value":36.15,"profit":true},{"date":"2022-12-31","value":3.22,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":95.58,"profit":true}]
Cost of Revenue130.94M121.88M10.11M9.21M8.66M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":93.07,"profit":true},{"date":"2022-12-31","value":7.72,"profit":true},{"date":"2023-12-31","value":7.03,"profit":true},{"date":"2024-12-31","value":6.62,"profit":true}]
Gross Profit(110.87M)40.96M3.65M113.31M108.30M[{"date":"2020-12-31","value":-97.85,"profit":false},{"date":"2021-12-31","value":36.15,"profit":true},{"date":"2022-12-31","value":3.22,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":95.58,"profit":true}]
Gross Margin(552.21%)100.00%100.00%100.00%100.00%[{"date":"2020-12-31","value":-552.21,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses42.51M167.98M166.37M181.30M218.71M[{"date":"2020-12-31","value":19.44,"profit":true},{"date":"2021-12-31","value":76.81,"profit":true},{"date":"2022-12-31","value":76.07,"profit":true},{"date":"2023-12-31","value":82.9,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(153.38M)(127.02M)(162.72M)(68.00M)(110.40M)[{"date":"2020-12-31","value":-15337700000,"profit":false},{"date":"2021-12-31","value":-12701600000,"profit":false},{"date":"2022-12-31","value":-16272000000,"profit":false},{"date":"2023-12-31","value":-6799600000,"profit":false},{"date":"2024-12-31","value":-11040300000,"profit":false}]
Total Non-Operating Income/Expense2.61M-3.15M--[{"date":"2020-12-31","value":82.88,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income(150.75M)(122.45M)(161.14M)(58.19M)(97.01M)[{"date":"2020-12-31","value":-15075100000,"profit":false},{"date":"2021-12-31","value":-12244900000,"profit":false},{"date":"2022-12-31","value":-16114200000,"profit":false},{"date":"2023-12-31","value":-5819000000,"profit":false},{"date":"2024-12-31","value":-9700800000,"profit":false}]
Income Taxes(841.00K)(204.00K)681.00K(677.00K)-[{"date":"2020-12-31","value":-123.49,"profit":false},{"date":"2021-12-31","value":-29.96,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-99.41,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(149.91M)-(161.82M)--[{"date":"2020-12-31","value":-14991000000,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-16182300000,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(149.91M)(122.25M)(161.82M)(57.51M)(97.01M)[{"date":"2020-12-31","value":-14991000000,"profit":false},{"date":"2021-12-31","value":-12224500000,"profit":false},{"date":"2022-12-31","value":-16182300000,"profit":false},{"date":"2023-12-31","value":-5751300000,"profit":false},{"date":"2024-12-31","value":-9700800000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(149.91M)(122.25M)(161.82M)(57.51M)(97.01M)[{"date":"2020-12-31","value":-14991000000,"profit":false},{"date":"2021-12-31","value":-12224500000,"profit":false},{"date":"2022-12-31","value":-16182300000,"profit":false},{"date":"2023-12-31","value":-5751300000,"profit":false},{"date":"2024-12-31","value":-9700800000,"profit":false}]
EPS (Diluted)(3.98)(2.37)(2.13)(0.55)(0.79)[{"date":"2020-12-31","value":-398,"profit":false},{"date":"2021-12-31","value":-237,"profit":false},{"date":"2022-12-31","value":-213,"profit":false},{"date":"2023-12-31","value":-55,"profit":false},{"date":"2024-12-31","value":-78.6,"profit":false}]

Wave Life Sciences Ltd Ratios

Wave Life Sciences Ltd Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

WVE
Cash Ratio 2.28
Current Ratio 2.51

Wave Life Sciences Ltd Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

WVE
ROA (LTM) -28.33%
ROE (LTM) -86.51%

Wave Life Sciences Ltd Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

WVE
Debt Ratio Lower is generally better. Negative is bad. 0.48
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.52

Wave Life Sciences Ltd Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

WVE
Trailing PE NM
Forward PE NM
P/S (TTM) 21.77
P/B 19.08
Price/FCF NM
EV/R 20.14
EV/Ebitda NM
PEG NM

FAQs

What is Wave Life Sciences Ltd share price today?

Wave Life Sciences Ltd (WVE) share price today is $12.68

Can Indians buy Wave Life Sciences Ltd shares?

Yes, Indians can buy shares of Wave Life Sciences Ltd (WVE) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in WVE stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Wave Life Sciences Ltd be purchased?

Yes, you can purchase fractional shares of Wave Life Sciences Ltd (WVE) via the Vested app. You can start investing in Wave Life Sciences Ltd (WVE) with a minimum investment of $1.

How to invest in Wave Life Sciences Ltd shares from India?

You can invest in shares of Wave Life Sciences Ltd (WVE) via Vested in three simple steps:

  • Click on Sign Up or Invest in WVE stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Wave Life Sciences Ltd shares
What is Wave Life Sciences Ltd 52-week high and low stock price?

The 52-week high price of Wave Life Sciences Ltd (WVE) is $21.73. The 52-week low price of Wave Life Sciences Ltd (WVE) is $5.28.

What is Wave Life Sciences Ltd price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Wave Life Sciences Ltd (WVE) is

What is Wave Life Sciences Ltd price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Wave Life Sciences Ltd (WVE) is 19.08

What is Wave Life Sciences Ltd dividend yield?

The dividend yield of Wave Life Sciences Ltd (WVE) is 0.00%

What is the Market Cap of Wave Life Sciences Ltd?

The market capitalization of Wave Life Sciences Ltd (WVE) is $2.38B

What is Wave Life Sciences Ltd's stock symbol?

The stock symbol (or ticker) of Wave Life Sciences Ltd is WVE

How Can Investors Use Wave Life Sciences Ltd Share Price Data for Long-Term Investment Decisions?

Consider the share price of Wave Life Sciences Ltd as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Wave Life Sciences Ltd has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Wave Life Sciences Ltd shares for Indian investors?

When investing in Wave Life Sciences Ltd shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Wave Life Sciences Ltd stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Wave Life Sciences Ltd share price with other stocks in the same sector?

Rather than merely checking the share price of Wave Life Sciences Ltd and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Wave Life Sciences Ltd stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top